Collect. Czech. Chem. Commun. 2006, 71, 912-928

Nucleoside Prodrugs of A3 Adenosine Receptor Agonists and Antagonists

Pedro Besadaa, Liaman K. Mamedovaa, Krishnan K. Palaniappana, Zhan-Guo Gaoa, Bhalchandra V. Joshia, Lak Shin Jeongb, Mortimer M. Civanc and Kenneth A. Jacobsona,*

a Molecular Recognition Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0810, U.S.A.
b Laboratory of Medicinal Chemistry, College of Pharmacy, Ewha Womans University, Seoul 120-750, Korea
c Departments of Physiology and Medicine, University of Pennsylvania, Philadelphia, PA, U.S.A.

Individual author index pages

Other CCCC articles of these authors

  • Philippe Van Rompaey, Kenneth A. Jacobson, Zhan-Guo Gao, Aishe Chen, Dov Barak, Soon-Ai Kim, Kyeong Lee, Andreas Link, Bruce T. Liang, Piet Herdewijn and Serge Van Calenbergh
    Amine-modified nucleosides as adenosine A3 neoceptor ligands
    Symposium Series 2002, Vol. 5, pp. 267–271 [Abstract]
    Published online 2016-01-25 20:41:17
  • Liesbet Cosyn, Kenneth A. Jacobson and Serge Van Calenbergh
    2-(1,2,3-Triazol-1-yl) N6-CH3-substituted adenosine derivatives: Highly potent and selective A3 receptor ligands
    Symposium Series 2005, Vol. 7, pp. 393–394 [Abstract]
    Published online 2015-11-08 11:56:11
  • Sara Van Poecke, Matt Barrett, Kenneth A. Jacobson, T. Kendall Harden and Serge Van Calenbergh
    Synthesis of base-substituted uridine 5'-phosphonate analogues as potential P2Y2 receptor ligands
    Symposium Series 2011, Vol. 12, pp. 485–486 [Abstract]
    Published online 2015-08-20 10:25:20